Image: Carl R. Sanchez

Carl R. Sanchez

Partner, Corporate Department


电话: 1(212) 318-6041
传真: 1(212) 303-7041


Carl R. Sanchez is a partner in the Corporate practice of Paul Hastings and is based in the firm’s New York and San Diego offices. 

Carl’s practice is primarily in the area of mergers and acquisitions, where he represents public and private companies in a wide variety of merger and acquisition transactions, including stock acquisitions, divisional asset acquisitions and divestitures, tender offers, and share exchange offers, restructurings, dissolutions, going-private transactions, joint ventures, distressed company acquisitions, cross-border acquisitions, and other business combination transactions. He has represented numerous public and private companies in the life sciences, technology, telecommunications, semiconductor, software, computer hardware, defense, entertainment, and financial services industries. Carl served as the Chair of the firm’s Mergers & Acquisitions Practice Group from 2003 through 2019. 

Between 1988 and 1990, Carl was an auditor and consultant in Deloitte & Touche’s New York office, specializing in investment banking and broker-dealer activities. From 1980 to 1986, Carl served in the United States Air Force Intelligence Division as a Russian crypto-linguist, where he received numerous awards for his service, including the Air Force Commendation Medal.


  • Recognized as a highly regarded lawyer by the IFLR1000 (2023)
  • Recognized in The Legal 500, M&A/Corporate and Commercial: M&A: Large Deals ($1BN+) (2022)
  • Recognized in Chambers USA, Corporate/M&A (2023 - 2024)
  • Awarded Southern California Super Lawyer (2007-2014) by Super Lawyers Magazine
  • Named 2013 Deal Maker of the Year by American Lawyer Magazine
  • Named an M&A MVP (2013) by Law 360
  • Cited in International Financial Law Review 1000 as a leading lawyer in the areas of Mergers and Acquisitions (2013)
  • Cited in Chambers USA: America’s Leading Lawyers for Business (2010-2013) in the area of Corporate/M&A
  • Cited as one of the leading mergers and acquisitions lawyers by The Legal 500 US (2010-2013)
  • Cited in The Best Lawyers in America (2011)
  • Voted 2009 Attorney of the Year in the area of Mergers and Acquisitions by the San Francisco Recorder


  • University of California, Los Angeles School of Law, J.D., 1993
  • University of Texas at San Antonio, B.B.A. in Accounting, 1988


  • Samsung Electronics Company in its acquisition of Harman-Kardon in a US$8.2 billion cash merger;
  • Ardea Biosciences in its sale to AstraZeneca in a US$1.3 billion cash merger;
  • Accelrys, Inc., in its US$780 million sale to Dassault Systemés in a cash tender offer;
  • Marvel Entertainment in its US$4 billion sale to The Walt Disney Company;
  • Shuanghui International Holdings Limited, China's largest meat processor, in its acquisition of Smithfield Foods, Inc. in a cash merger valued at US$7.1 billion;
  • ABC-Mart, Inc., Japan's largest shoe retailer, in its US$138 million acquisition of U.S. based LaCrosse Footwear, Inc.;
  • Dubai World, an international holding company, in its US$5.1 billion investment in MGM MIRAGE pursuant to a public tender offer and joint venture;
  • Applied Micro Circuits Corporation in its US$4.5 billion acquisition of MMC Networks, Inc. in a negotiated one-step merger;
  • QUALCOMM Incorporated in the divestiture of its infrastructure division to Ericsson L.M. Telefonaktielbolaget and in the divestiture of its handset division to Kyocera International, and in QUALCOMM’s US$1 billion acquisition of Snaptrack, Inc.;
  • Bolthouse Farms in its US$1.2 billion leveraged buy-out by Madison Dearborn Partners;
  • Avalon Ventures in its US$495 million strategic collaboration with GlaxoSmithKline;
  • Certain Rooney family members in the sale of their interests in the Pittsburgh Steelers NFL franchise in a transaction valued at US$800 million;
  • Micromuse, Inc. in its US$865 million acquisition by IBM;
  • Citigroup in its acquisition of the Diners Club Europe franchise of businesses in a transaction valued at over US$700 million; and
  • Aurora Biosciences, Inc. in the sale of the company to Vertex Pharmaceuticals, Inc. for US$600 million in a reverse triangular merger.

Engagement & Publications

  • Frequent lecturer on mergers and acquisitions topics
  • Authored articles on mergers and acquisitions related issues


  • Member of the California Bar
  • Member of the Business Law section of the American Bar Association

Practice Areas

Mergers and Acquisitions



Life Sciences and Healthcare






New York Bar

District of Columbia Bar

California Bar


UCLA School of Law, J.D. 1993

The University of Texas at San Antonio, B.B.A. 1988